Knowledge Distillery

Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic.

While neuropathological examinations in patients who died from COVID-19 revealed inflammatory changes in cerebral white matter, cerebral MRI…

It is increasingly acknowledged that Coronavirus Disease 2019 (COVID-19) can have neurological manifestations, and cerebral microbleeds (CMBs) have…

The goal of this work was to evaluate whether patients with epilepsy were more susceptible to COVID-19 infection and at greater risk of severe…

The objective of this multi-center, retrospective, cohort study was to estimate the time to recovery of command-following and associations between…

Alzheimer’s disease (AD) and COVID-19 share common risk factors including hypertension. Angiotensin converting enzyme inhibitors (ACEI) and…

Data from the early pandemic revealed that 0.62% of children hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had an…

The authors compared mortality rates in 2020 (March-December) with rates in 2019 for the same period among 53 640 888 Medicare enrollees >…

To determine the impact of MS disease-modifying therapies (DMTs) on the development of cellular and humoral immunity to SARS-CoV-2 infection.

There is strong evidence for brain-related abnormalities in COVID-19. It remains unknown however whether the impact of SARS-CoV-2 infection can be…

Despite the increasing number of reports on the spectrum of neurological manifestations of COVID-19 (neuro-COVID), few studies have assessed short-…

Fatigue and cognitive difficulties are reported as the most frequently persistent symptoms in patients after mild SARS-CoV-2 infection.